A comparison of the effect of a blood component and steroid injection in the wrist of patients with carpal tunnel syndrome
Phase 2
Completed
- Conditions
- Health Condition 1: null- Carpal Tunnel syndromeHealth Condition 2: G560- Carpal tunnel syndrome
- Registration Number
- CTRI/2017/09/009696
- Lead Sponsor
- Department of PMR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 84
Inclusion Criteria
1. Clinically diagnosed cases of Carpal Tunnel Syndrome
2. Failure of conservative management for 4 weeks
Exclusion Criteria
1.Local skin infection at the site of injection
2.Diagnosed cases of platelet dysfunction and Thrombocytopenia (Platelet <1.5 lakhs)
3.Diagnosed cases of Malignancy
4.Uncontrolled endocrine dysfunction (Type 2 Diabetes mellitus (FBS >110mg/dl, PPBS >140mg/dl), Hypothyroidism ( >3.3mIU/L) )
Hb < 10 gm%
5.Severe CTS with thenar muscle atrophy (Mackinnsonââ?¬•s classification)
6.Diagnosed cases of rheumatoid arthritis
7.Prior surgery or fracture in the same wrist
8.Prior steroid injection in the same wrist within 6 months of the study
9.Patient on anticoagulant therapy
10.Refusal to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in functional outcome (BCTQ-functional outcome score)Timepoint: 4th week and 12th week
- Secondary Outcome Measures
Name Time Method Changes in CSA of median nerve at carpal tunnel (USG)Timepoint: 4th week and 12th week;Improvement in symptom severity (BCTQ- symptom severity score)Timepoint: 4th week and 12th week